drugset / Trial / NCT03173599
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
A Safety and Tolerability Evaluation of Ascending Single Oral Doses of Metacavir Enteric-coated Capsules Using a Randomized，Double-blind, Placebo-controlled Design conducted in Chinese Healthy Adult Volunteers.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metacavir | Small molecule | 40 mg | Oral |
| Subject | Metacavir | Small molecule | 80 mg | Oral |
| Subject | Metacavir | Small molecule | 160 mg | Oral |
| Subject | Metacavir | Small molecule | 240 mg | Oral |
| Subject | Metacavir | Small molecule | 360 mg | Oral |
| Subject | Metacavir | Small molecule | 480 mg | Oral |